Paper39635534
COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.
He N and 5 others. Front Immunol, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. Papers, record 39635534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635534
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| COVID-19 | Major topic |
| Protein Kinase Inhibitors | Major topic |
| SARS-CoV-2 | Major topic |
| Fusion Proteins, bcr-abl | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Adult | |
| Aged | |
| T-Lymphocytes |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35818053 | A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35818053 | PubMed |
| 2 | 35068289 | Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study. | Leuk Lymphoma | 2022 | https://conductscience.org/library/papers/35068289 | PubMed |
| 3 | 32998157 | COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. | Nature | 2020 | https://conductscience.org/library/papers/32998157 | PubMed |
| 4 | 33435150 | Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future. | Cells | 2021 | https://conductscience.org/library/papers/33435150 | PubMed |
| 5 | 36276065 | Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase. | Front Oncol | 2022 | https://conductscience.org/library/papers/36276065 | PubMed |
| 6 | 36580318 | Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/36580318 | PubMed |
| 7 | 28359029 | Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much. | Leuk Res | 2017 | https://conductscience.org/library/papers/28359029 | PubMed |
| 8 | 32424293 | COVID-19 in persons with chronic myeloid leukaemia. | Leukemia | 2020 | https://conductscience.org/library/papers/32424293 | PubMed |
| 9 | 32066541 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/32066541 | PubMed |
| 10 | 33168949 | Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. | Leukemia | 2021 | https://conductscience.org/library/papers/33168949 | PubMed |
| 11 | 35619871 | Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report. | Cureus | 2022 | https://conductscience.org/library/papers/35619871 | PubMed |
| 12 | 36125379 | Pulmonary Dysfunction after Pediatric COVID-19. | Radiology | 2023 | https://conductscience.org/library/papers/36125379 | PubMed |
| 13 | 35176326 | COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. | Kidney Int | 2022 | https://conductscience.org/library/papers/35176326 | PubMed |
| 14 | 33014780 | Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2. | Front Oncol | 2020 | https://conductscience.org/library/papers/33014780 | PubMed |
| 15 | 17032128 | Westgard multirule for calculated laboratory tests. | Clin Chem Lab Med | 2006 | https://conductscience.org/library/papers/17032128 | PubMed |
| 16 | 32839569 | Not just antibodies: B cells and T cells mediate immunity to COVID-19. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/32839569 | PubMed |
| 17 | 32866033 | Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. | Am J Respir Crit Care Med | 2020 | https://conductscience.org/library/papers/32866033 | PubMed |
| 18 | 34182569 | SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. | Nature | 2021 | https://conductscience.org/library/papers/34182569 | PubMed |
| 19 | 31289206 | Human BCR/ABL1 induces chronic myeloid leukemia-like disease in zebrafish. | Haematologica | 2020 | https://conductscience.org/library/papers/31289206 | PubMed |
| 20 | 34708401 | Is COVID-19 less severe in CML patients than in those with other haematological cancers? | Br J Haematol | 2022 | https://conductscience.org/library/papers/34708401 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39635534
GET https://conductscience.org/api/papers/v1/39635534/references?page=2